Lupus Stem Cell Treatment at Giostar – Patient Testimonial
Lupus Stem Cell Therapy at Giostar – Patient Testimonial
Orthopaedics Stem Cell Treatment at Giostar – Patient Testimonial
Orthopaedics Stem Cell Therapy at Giostar – Patient Testimonial
GIOSTAR Chairman Dr Anand Srivastava Keynote Speaker at Aesthetic & Anti-Aging Medicine World Congress Latin America
GIOSTAR Chairman Dr Anand Srivastava Keynote Speaker at Aesthetic & Anti-Aging Medicine World Congress Latin America
Medellin, Columbia November 2017
-
- Aesthetic & Anti-Aging Medicine World Congress
Aesthetic & Anti-Aging Medicine World Congress1
-
- Aesthetic & Anti-Aging Medicine World Congress
-
- Aesthetic & Anti-Aging Medicine World Congress
Aesthetic & Anti-Aging Medicine World Congress3
-
- Aesthetic & Anti-Aging Medicine World Congress
-
- Aesthetic & Anti-Aging Medicine World Congress
-
- Aesthetic & Anti-Aging Medicine World Congress
-
- Aesthetic & Anti-Aging Medicine World Congress
Aesthetic & Anti-Aging Medicine World Congress
-
- Aesthetic & Anti-Aging Medicine World Congress
GIOSTAR CEO Mr Deven Patel Lecture at BAPS Swaminarayan Vidyamandir Girls School
GIOSTAR CEO Mr Deven Patel Lecture at BAPS Swaminarayan Vidyamandir Girls School
-
- GIOSTAR CEO Mr Deven Patel Lecture at BAPS Swaminarayan Vidyamandir Girls School
Open Journal of Organ Transplant Surgery (OJOTS) requesting scientific manuscript from GIOSTAR Chairman Dr. Anand Srivastava
Open Journal of Organ Transplant Surgery (OJOTS) |
|
| Dear Anand S Srivastava, | |
|
In view of your valuable publications in academic circle, we hereby invite you to submit your current scientific manuscripts to “Open Journal of Organ Transplant Surgery” ( ISSN Online: 2163-9493), a peer-reviewed open-access journal. |
|
| The manuscripts are expected to be submitted through our Manuscript Tracking System. If you have difficulties in logging in our Online Submission System, please send the papers directly to this e-mail (unified naming format of mail theme: 209 – “Article Title”), we will upload your papers to our system within 24 hours. | |
|
Potential Topics (not limited to) |
|
| Allograft and allotransplantation | Isograft |
| Autograft | Transplant rejection |
| Cadaveric (non-living) donors | Split transplants |
| Domino transplants | Xenograft and xenotransplantation |
| Published Articles in OJOTS | |
| Antimicrobial Effect of Skin for Allograft and Management in Burn Wound Kihwan Lim, Cheonjae Yoon, Jungsuk Lee |
|
| A Modified, Rapid and Safe Technique of Kidney Only Procurement from Donors after Circulatory and Brain Death (DCD, DBD) André G. Baranski, Hwai-Ding Lam |
|
| The Effect of Non-Invasive Goal Directed Fluid Administration on Graft Function in Deceased Donor Renal Transplantation: A Pilot Study Joseph R. Whiteley, Jason M. Taylor, John J. Freely Jr., Thomas I. Epperson, Laura Bell, John L. Murray IV, Charles F. Bratton, William R. Hand |
|
| Important Issues | |
| Deadline: July 25th, 2017 | |
| Publication Date: August 2017 | |
| There is no charge for publishing articles in this journal now | |
| Best regards, | |
| Prof. Rubin Zhang (Tulane University, USA) | |
| Editor-in-Chief | |
| OJOTS Editorial Office | |
IDDST-Japan 2017 – Spraker Invitation at 15th Annual Congress of International Drug Discovery Science & Technology
IDDST-Japan 2017 – Spraker Invitation at 15th Annual Congress of International Drug Discovery Science & Technology
Dear Anand S. Srivastava,
Hope you everything goes well.
I apologize for the inconvenience if the letter disturbed you more than once due to the non-feedback of last one.
It is our great pleasure to welcome you to join the 15th Annual Congress of International Drug Discovery Science & Technology – Japan 2017 (IDDST-Japan 2017) with the theme “Dedicated to Accelerating Drug Innovation”, which will be held during July 25-27, 2017 at Osaka, Japan. And we cordially invite you to propose a Speech on your recent drug discovery project in the field ofTherapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine… for the Section 2: Discovery Chemistry & Drug Design at IDDST-Japan 2017. Your prompt reply with a speech proposal (Speech Title and abstract preferred along with full CV) will be highly appreciated!
IDDST-Japan 2017 covers Keynote Forum and 6 Parts, totally 30 Sessions as well as other exciting social events. So far, we have received more than 500 positive feedbacks by industrial and academic experts all of the world, and almost 100 excellent speakers already registered and confirmed their participation. Please find part of confirmed speakers as below. The full program has been released online and you may check more information of potential speakers and theirnovel topics! As we still have about 4 months to the event, we believe the IDDST-Japan 2017 will be the most successful annual conference than ever!
We sincerely hope you can join in us next July, please kindly let us know your opinion. Look forward to seeing you in amazing OSAKA for a stimulating and enjoyable conference!
Sincerely yours,
Ms. Irene Wang
Organizing Committee of IDDST-Japan 2017
Part of Confirmed Speakers in Business
Dr. Helmut Haning, Senior Vice President, Bayer Pharma Aktiengesellschaft, Germany
Dr. Litao Zhang, Vice President & Leads Discovery Optimization, Bristol-Myers Squibb, USA
Dr. Akiyoshi Suganuma, Group Officer, BA-CFU President, Eisai Co., Ltd., Japan
Dr. David C. Bunton, CEO, ReproCELL Group Companies, Japan
Dr. Giovanna Bergamini, Director Discovery Biology and GSK Fellow, GSK, Germany
Dr. Dinah Weissmann, Executive VP R&D, Alcediag, France
Dr. Teresa Tarrago, Chief Executive Officer, Iproteos S.L., Spain
Dr. Joseph P. Thomas, Chair of the Life Sciences Group and Co-chair of the Litigation Department, Ulmer & Berne LLP, USA
Dr. Graeme Ladds, Operations Director & CEO, PharSafer Associates Ltd, USA
Dr. Helmut Thomas, President and CEO, Cyclenium Pharma Inc., Canada
Dr. Gerhard Muller, Senior Vice President, Mercachem, The Netherlands
Dr. Junsang Park, Vice President, GL PharmTech, South Korea
Dr. Dieter Lubda, Director, Actives & Formulation R&D Operations, Merck KGaA, Germany
Dr. Fredrik Sundberg, Global Director, GE Healthcare, Sweden
Dr. Shu-Hui Liu, Director, Pfizer Inc., USA
Dr. Jean-Christophe Carry, Group Leader, Medicinal Chemistry, Sanofi, France
Dr. Andreas Haupt, Associate Director, Department of Medicinal Chemistry, AbbVie Deutschland GmbH & Co. KG, Germany
Dr. Stefan Bassarab, Senior Manager, Drug Product Development and Drug Delivery, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Dr. Lars Barfacker, Principal Scientist, Bayer Pharma, Germany
Dr. Andrzej Joachimiak, Program Director, Structural Biology Center, Argonne National Laboratory; Sr. Biophysicist, Argonne, USA
Dr. Gary Henniger, Director Engineering, Teva Global Respiratory R&D, Israel
Part of Confirmed Speakers in Academia
Dr. Paul L. Kaufman, Professor, University of Wisconsin-Madison, USA
Dr. Martin Dawes, Royal Canadian Legion Professor and Head, Department of Family Practice, The University of British Columbia, Canada
Dr. William Lawson, Professor & Associate Dean for Health Disparities, The University of Texas at Austin, USA
Dr. Branko Stefanovic, Professor, Florida State University, USA
Dr. Shaker A. Mousa, Vice Provost for Research Professor of Pharmacology, Albany College of Pharmacy and Health Sciences, USA
Dr. Youla S. Tsantrizos, Professor, McGill University, Canada
Dr. Randolph D Glickman, Professor, University of Texas Health Science Center, USA
Dr. Magdy El-Salhy, Professor, University of Bergen, Norway
Dr. Nissim Garti, Professor, The Institute of Chemistry, s, Israel
Dr. Hongtao Jin, Associate Professor and Vice Director, New Drug Safety Evaluation Center (NDSEC), Chinese Academy of Medical Sciences & Peking Union Medical College, China
Dr. Tsuchida Kunihiro, Professor, Fujita Health University, Japan
Dr. Dmitry Aminin, Head, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Russia
